185 related articles for article (PubMed ID: 15477999)
1. Differences in the fusion and resorption activity of human osteoclasts after stimulation with different growth factors released from a polylactide carrier.
Wildemann B; Kadow-Romacker A; Lübberstedt M; Raschke M; Haas NP; Schmidmaier G
Calcif Tissue Int; 2005 Jan; 76(1):50-5. PubMed ID: 15477999
[TBL] [Abstract][Full Text] [Related]
2. [Experimental fusion of the sheep cervical spine. Part II: Effect of growth factors and carrier systems on interbody fusion].
Kandziora F; Scholz M; Pflugmacher R; Krummrey G; Schollmeier G; Schmidmaier G; Schnake KJ; Duda G; Raschke M; Haas NP
Chirurg; 2002 Oct; 73(10):1025-38. PubMed ID: 12395162
[TBL] [Abstract][Full Text] [Related]
3. Local and controlled release of growth factors (combination of IGF-I and TGF-beta I, and BMP-2 alone) from a polylactide coating of titanium implants does not lead to ectopic bone formation in sheep muscle.
Wildemann B; Kandziora F; Krummrey G; Palasdies N; Haas NP; Raschke M; Schmidmaier G
J Control Release; 2004 Mar; 95(2):249-56. PubMed ID: 14980773
[TBL] [Abstract][Full Text] [Related]
4. IGF-I and TGF-beta 1 incorporated in a poly(D,L-lactide) implant coating maintain their activity over long-term storage-cell culture studies on primary human osteoblast-like cells.
Wildemann B; Lübberstedt M; Haas NP; Raschke M; Schmidmaier G
Biomaterials; 2004 Aug; 25(17):3639-44. PubMed ID: 15020138
[TBL] [Abstract][Full Text] [Related]
5. IGF-I and TGF-beta 1 incorporated in a poly(D,L-lactide) implant coating stimulates osteoblast differentiation and collagen-1 production but reduces osteoblast proliferation in cell culture.
Schmidmaier G; Wildemann B; Lübberstedt M; Haas NP; Raschke M
J Biomed Mater Res B Appl Biomater; 2003 Apr; 65(1):157-62. PubMed ID: 12632385
[TBL] [Abstract][Full Text] [Related]
6. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts.
Perez-Amodio S; Beertsen W; Everts V
J Bone Miner Res; 2004 Oct; 19(10):1722-31. PubMed ID: 15355568
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation.
Wutzl A; Brozek W; Lernbass I; Rauner M; Hofbauer G; Schopper C; Watzinger F; Peterlik M; Pietschmann P
J Biomed Mater Res A; 2006 Apr; 77(1):75-83. PubMed ID: 16355411
[TBL] [Abstract][Full Text] [Related]
8. IGF-I and TGF-beta1 application by a poly-(D,L-lactide)-coated cage promotes intervertebral bone matrix formation in the sheep cervical spine.
Kandziora F; Schmidmaier G; Schollmeier G; Bail H; Pflugmacher R; Görke T; Wagner M; Raschke M; Mittlmeier T; Haas NP
Spine (Phila Pa 1976); 2002 Aug; 27(16):1710-23. PubMed ID: 12195060
[TBL] [Abstract][Full Text] [Related]
9. Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating.
Greiner S; Kadow-Romacker A; Schmidmaier G; Wildemann B
J Biomed Mater Res A; 2009 Oct; 91(1):288-95. PubMed ID: 18980195
[TBL] [Abstract][Full Text] [Related]
10. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
Shui C; Riggs BL; Khosla S
Calcif Tissue Int; 2002 Nov; 71(5):437-46. PubMed ID: 12202955
[TBL] [Abstract][Full Text] [Related]
11. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
Kanatani M; Sugimoto T; Kaji H; Kobayashi T; Nishiyama K; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944
[TBL] [Abstract][Full Text] [Related]
12. Comparison of BMP-2 and combined IGF-I/TGF-ss1 application in a sheep cervical spine fusion model.
Kandziora F; Pflugmacher R; Scholz M; Knispel C; Hiller T; Schollmeier G; Bail H; Schmidmaier G; Duda G; Raschke M; Haas NP
Eur Spine J; 2002 Oct; 11(5):482-93. PubMed ID: 12384758
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent effects of combined IGF-I and TGF-beta1 application in a sheep cervical spine fusion model.
Kandziora F; Pflugmacher R; Scholz M; Schäfer J; Schollmeier G; Schmidmaier G; Duda G; Raschke M; Haas NP
Eur Spine J; 2003 Oct; 12(5):464-73. PubMed ID: 14618385
[TBL] [Abstract][Full Text] [Related]
14. Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation.
Lind M
Acta Orthop Scand Suppl; 1998 Oct; 283():2-37. PubMed ID: 9856074
[TBL] [Abstract][Full Text] [Related]
15. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
16. Collective review: bioactive implants coated with poly(D,L-lactide) and growth factors IGF-I, TGF-beta1, or BMP-2 for stimulation of fracture healing.
Schmidmaier G; Lucke M; Schwabe P; Raschke M; Haas NP; Wildemann B
J Long Term Eff Med Implants; 2006; 16(1):61-9. PubMed ID: 16566746
[TBL] [Abstract][Full Text] [Related]
17. Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts.
Otsuka E; Notoya M; Hagiwara H
Calcif Tissue Int; 2003 Jul; 73(1):72-7. PubMed ID: 14506957
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
19. Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats.
Schmidmaier G; Wildemann B; Bail H; Lucke M; Fuchs T; Stemberger A; Flyvbjerg A; Haas NP; Raschke M
Bone; 2001 Apr; 28(4):341-50. PubMed ID: 11336914
[TBL] [Abstract][Full Text] [Related]
20. Osteoclastogenesis in the nonadherent cell population of human bone marrow is inhibited by rhBMP-2 alone or together with rhVEGF.
Wan C; He Q; Li G
J Orthop Res; 2006 Jan; 24(1):29-36. PubMed ID: 16419966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
